LPL Financial’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
SEP
LPL Financial's FLNA Position: Q3 2026 in Review
LPL Financial reduced its Filana Therapeutics (FLNA) stake by 1.3% in Q3 2026, selling an estimated $499 and leaving 39,643 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6160.
LPL Financial first reported a position in FLNA in Q3 2021 and has held it in 21 quarters since. The position peaked at $2.34M in Q3 2024. 24 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.
- LPL Financial held 39,643 shares of Filana Therapeutics worth $35.1K as of Q3 2026.
- LPL Financial sold 529 Filana Therapeutics shares in Q3 2026, an estimated $499.
- Filana Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #6160 holding.
- LPL Financial first reported a position in Filana Therapeutics in Q3 2021 and has held it in 21 quarters since.
- LPL Financial's Filana Therapeutics position peaked at $2.34M in Q3 2024.
- 24 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.